1. Home
  2. OGE vs RGEN Comparison

OGE vs RGEN Comparison

Compare OGE & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OGE Energy Corp

OGE

OGE Energy Corp

N/A

Current Price

$43.17

Market Cap

8.8B

Sector

Utilities

ML Signal

N/A

Logo Repligen Corporation

RGEN

Repligen Corporation

N/A

Current Price

$171.09

Market Cap

8.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OGE
RGEN
Founded
1902
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Medical/Dental Instruments
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
8.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
OGE
RGEN
Price
$43.17
$171.09
Analyst Decision
Buy
Buy
Analyst Count
10
11
Target Price
$47.30
$177.18
AVG Volume (30 Days)
1.3M
570.0K
Earning Date
02-18-2026
02-19-2026
Dividend Yield
3.89%
N/A
EPS Growth
29.01
N/A
EPS
2.49
0.03
Revenue
$3,294,800,000.00
$707,890,000.00
Revenue This Year
$6.42
$17.86
Revenue Next Year
$4.63
$12.44
P/E Ratio
$17.55
$6,679.64
Revenue Growth
18.03
11.74
52 Week Low
$40.80
$102.97
52 Week High
$47.33
$182.52

Technical Indicators

Market Signals
Indicator
OGE
RGEN
Relative Strength Index (RSI) 50.25 60.58
Support Level $42.91 $157.29
Resistance Level $44.17 $172.51
Average True Range (ATR) 0.71 6.60
MACD 0.15 0.00
Stochastic Oscillator 63.22 75.32

Price Performance

Historical Comparison
OGE
RGEN

About OGE OGE Energy Corp

OGE Energy is a holding company for Oklahoma Gas & Electric, a regulated utility with electricity generation, transmission, and distribution service for 900,000 customers in Oklahoma and western Arkansas. In December 2021, OGE divested its 25.5% stake in Enable Midstream Partners, an oil and gas services company it created in 2013 through a unit exchange merger with Energy Transfer. OGE sold its 95.4 million limited partner units of Energy Transfer throughout 2022. OGE sold its retail gas business in 1928 and no longer has any gas operations.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: